companies / crossbowtx-com
Generated UTC · publication cutoff 2026-11-09
Insufficient cited evidence for a two-sentence summary.
verified=2026-05-19 json
| total_raised | 198,000,000198.0M | ○ |
|---|---|---|
| founded | 2021 | |
| hq | Cambridge, USA | |
| industry | unknown | |
| stage | series-b+ |
Crossbow Therapeutics develops TCR-mimetic antibody therapies, its T-Bolt molecules, letting off-the-shelf T-cell engagers reach intracellular cancer proteins. It serves biopharma and patients with solid and blood cancers, targeting proteins like TERT. Its edge is opening the full universe of cancer proteins as drug targets.
No cited completed company acquisition recorded.
Dated disclosures. Customer relationships and classifications are historical; ARR is separate from revenue.
No cited disclosure recorded: named customer, disclosed revenue, ARR, count, B2B / B2C, sector, go-to-market.
No cited valuation with an explicit basis is recorded.
Historical post-money / actual annual or stated TTM revenue. Same currency; economic valuation date within 90 days of revenue period end, inclusive. No FX, ARR, annualized revenue, estimates or projections. Conflicts and ambiguous ties are withheld.
No qualifying pair recorded.
| date | type | amount | lead | src |
|---|---|---|---|---|
| 2026-03-01 | series-b | 77,000,00077.0M | null | ○ |
Google Cloud CDN, Sentry, Partytown, Vercel Speed Insights, WebsiteBuilder, Wix, Google Cloud, React, lodash .
| fact | status | src |
|---|---|---|
| Series B, $77.0M | attributed | ○ |
| existence | self-reported | WEB |
| description | self-reported | WEB |